Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. OKYO.L Share Price
  4. OKYO.L Share Regulatory News
  5. ADS Program collapse

Pin to quick picksOKYO.L Regulatory News (OKYO)

OKYO.L Information
  • There is currently no data for OKYO

ADS Program collapse

19 May 2023 08:00

RNS Number : 9540Z
OKYO Pharma Limited
19 May 2023
 

 

OKYO PHARMA LIMITED

ADS Program collapse - Commencement of trading of new ordinary shares on The Nasdaq Capital Market

LONDON and NEW YORK, May 19, 2023 -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) hereby announces that following the implementation of the share capital consolidation and collapse of its ADS program, it is expected that new OKYO ordinary shares will be listed on The Nasdaq Capital Market with effect from the opening of business in New York on Monday May, 22, 2023.

OKYO has been listed on The Nasdaq Capital Market via an ADS since May 17 2022. OYKO announced its intention to delist from the London Stock Exchange plc on April 2, 2023 and on May 3, 2023 shareholders passed the necessary resolutions to consolidate its existing ordinary shares by a 65 into 1 reverse split (thereby matching the current ADS ratio of 65 ordinary shares comprised in each ADS). Each new OKYO ordinary share will accordingly represent 65 of the old ordinary shares and be equal to one ADS.

The CUSIP for the new OKYO ordinary shares is G6724L116 and the ISIN is GG00BMFG5F62.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKSPFSNDEFA
1234567
Date   Source Headline
14th Oct 20204:40 pmRNSSecond Price Monitoring Extn
14th Oct 20204:36 pmRNSPrice Monitoring Extension
14th Oct 20202:05 pmRNSSecond Price Monitoring Extn
14th Oct 20202:00 pmRNSPrice Monitoring Extension
13th Oct 20204:41 pmRNSSecond Price Monitoring Extn
13th Oct 20204:36 pmRNSPrice Monitoring Extension
13th Oct 20202:05 pmRNSSecond Price Monitoring Extn
13th Oct 20202:00 pmRNSPrice Monitoring Extension
13th Oct 202011:05 amRNSSecond Price Monitoring Extn
13th Oct 202011:00 amRNSPrice Monitoring Extension
9th Oct 20202:05 pmRNSSecond Price Monitoring Extn
9th Oct 20202:00 pmRNSPrice Monitoring Extension
9th Oct 202011:05 amRNSSecond Price Monitoring Extn
9th Oct 202011:00 amRNSPrice Monitoring Extension
9th Oct 20209:05 amRNSSecond Price Monitoring Extn
9th Oct 20209:00 amRNSPrice Monitoring Extension
25th Sep 20204:40 pmRNSSecond Price Monitoring Extn
25th Sep 20204:35 pmRNSPrice Monitoring Extension
25th Sep 202012:00 pmRNSUpload of Articles of Association to NSM
25th Sep 202012:00 pmRNSNotice of Results: AGM
9th Sep 20207:00 amRNSNotice of AGM
8th Sep 20209:17 amRNSIssue of convertible loan notes
21st Aug 20207:00 amRNSGrant of options – Director dealings
19th Aug 20207:00 amRNSDr. Napoleone Ferrara to Serve on the SAB
18th Aug 20202:06 pmRNSSecond Price Monitoring Extn
18th Aug 20202:01 pmRNSPrice Monitoring Extension
18th Aug 20207:00 amRNSOKYO: CLNs to raise £1.4m, intends to list: NASDAQ
17th Aug 20205:00 pmRNSFinal audited results for year ended 31 March 2020
17th Aug 20204:41 pmRNSSecond Price Monitoring Extn
17th Aug 20204:35 pmRNSPrice Monitoring Extension
7th Aug 20207:00 amRNSDr James Khodabakhsh MD named Chairman of the SAB
6th Aug 20207:00 amRNSHolding(s) in Company
3rd Aug 20204:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20204:35 pmRNSPrice Monitoring Extension
3rd Aug 20202:05 pmRNSSecond Price Monitoring Extn
3rd Aug 20202:00 pmRNSPrice Monitoring Extension
3rd Aug 202011:05 amRNSSecond Price Monitoring Extn
3rd Aug 202011:00 amRNSPrice Monitoring Extension
3rd Aug 20209:05 amRNSSecond Price Monitoring Extn
3rd Aug 20209:00 amRNSPrice Monitoring Extension
28th Jul 20208:51 amRNSIssue of convertible loan notes
10th Jun 20204:42 pmRNSDirectorate Change
5th Jun 202010:32 amRNSNotification of Major Holdings
3rd Jun 202011:09 amRNSAppointment of Broker
29th May 20206:09 pmRNSCLN Issue
28th May 20206:20 pmRNSPlacing update
27th May 20202:13 pmRNSHolding(s) in Company
27th Apr 202010:45 amRNSHolding(s) in Company
30th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSUpdate on Placing to raise £560,000
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
7DIG
7DIG.L
LSE
0.00%
0FSN
0FSN.L
LSE
0.00%
BVC
Batm Advanced
LSE
-0.40%
CGT
Capital Gearing Trust
LSE
-0.19%
OKYO
OKYO.L
LSE
0.00%
Trending
SBTX
Skinbiotherap.
LSE
0.00%
PLE
Plethora Solutions Holdings Plc
LSE
0.00%
CMET
Capital Metals
LSE
-0.97%
ALRT
Defence Holdings
LSE
19.05%
IMM
Immupharma
LSE
-2.26%